Skip to main content
. 2015 Mar 15;8(3):4122–4127.

Figure 1.

Figure 1

Percent of estrous cycle disorders before and after HCMNC transplantation in mice with POF. Group A, control group (n = 35); Group B, POF control group (n = 35); Group C, POF + HCMNC transplantation group (n = 35). The percent of estrous cycle disorders before and after transplantation were compared between the three groups. HCMNC: human cord blood mononuclear cell; POF: premature ovarian failure.